Margaret A. Alexander
Known title: President and COOCIK: 0002036798
Margaret A. Alexander's purchase track record
Margaret A. Alexander has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/27/2025 | OVID | $5K | -52.2% | -27.9% | +6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OVID | ▼ Sell | Open Market | 11,656 | $17K | 2/23/2026 | View on chart |
| OVID | ▼ Sell | Open Market | 5,279 | $3K | 2/26/2025 | View on chart |
| OVID | ▲ Buy | Grant | 43,750 | $0 | 2/20/2025 | View on chart |
| OVID | ▲ Buy | Open Market | 6,810 | $5K | 1/27/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Ovid Therapeutics shares decline in pre-market session
Ovid Therapeutics stock fell during Tuesday's pre-market trading, joining a group of larger companies experiencing similar declines. The drop brings the stock closer to its recent support level of $2.38. This movement occurs while the average analyst price target remains significantly higher at $5.92.
Ovid Therapeutics shares decline in pre-market session. Ovid Therapeutics stock fell during Tuesday's pre-market trading, joining a group of larger companies experiencing similar declines. The drop brings the stock closer to its recent support level of $2.38. This movement occurs while the average analyst price target remains significantly higher at $5.92.